China RNA Activation Venture Ractigen Looks To Clinic For Validation informa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from informa.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ On March 17, 2022, China National Drug Administration Drug Review Center (CDE) approved first Universal Chemeric Antigen Receptor T (UCAR-T).
/PRNewswire/ On March 17, 2022, China National Drug Administration Drug Review Center (CDE) approved first Universal Chemeric Antigen Receptor T (UCAR-T).
/PRNewswire/ Recently, Nanjing Bioheng Biotech Co., Ltd. ( hereinafter referred to as Bioheng) announced that its anti-claudin 18.2 autologous CAR-T cell.
[maximum single financing! Is "flying car" a tuyere or Bubble? On October 19th, Xiaopeng Automobile Ecological Enterprise Xiaopeng Huitian announced that it had completed round A financing of more than US $500m, with a pre-investment valuation of more than US $1 billion. It is reported that this round of financing is led by IDG Capital, Wuyuan Capital and Xiaopeng Automobile, followed by Sequoia Capital China, Zhong Ding Capital, GGV GGV Capital, Hillhouse Venture Capital, Yunfeng Fund and other well-known institutions.